Institutional Ownership
Addex Therapeutics Ltd
CUSIP 00654J206ADRADXNQ1 2026
13D / 13G Filings
5
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
14.2%
Max % of class reported
Institutional Holders
4
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
5 filings · latest Jun 23, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jun 23, 2025 | Timothy Mark Dyer | 13D/A | 12.9% | — | SEC |
| 2 | Aug 14, 2024 | Growth Equity Opportunities Fund IV, LLC | 13D/A | — | — | SEC |
| 3 | Aug 5, 2024 | Growth Equity Opportunities Fund IV, LLC | 13D/A | 5.1% | 6.62M | SEC |
| 4 | Dec 8, 2023 | Growth Equity Opportunities Fund IV, LLC | 13D/A | 6.4% | 7.70M | SEC |
| 5 | Nov 29, 2023 | Dyer Timothy Mark | 13D/A | 14.2% | 16.86M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Morgan Stanley | 301 | $1.9K |
| 2 | Gamma Investing LLC | 81 | $509 |
| 3 | Rhumbline Advisers | 72 | $450 |
| 4 | Sbi Securities Co., Ltd. | 1 | $6 |